Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with Type 2 diabetes

被引：0
|
作者：
DeFronzo, R
Ratner, R
Han, J
Kim, D
Fineman, M
Baron, A
机构：
[1] Univ Texas, Hlth Sci Ctr, Diabet Div, San Antonio, TX USA
[2] George Washington Univ, Sch Med, Dept Med, Bethesda, MD USA
[3] Amylin Pharmaceut Inc, Clin Affairs, San Diego, CA USA
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
775
引用
收藏
页码：A280 / A280
页数：1
相关论文
共 50 条
  • [1] Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
    DeFronzo, RA
    Ratner, RE
    Han, J
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETES CARE, 2005, 28 (05) : 1092 - 1100
  • [2] Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
    Kendall, DM
    Riddle, MC
    Rosenstock, J
    Zhuang, DL
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETES CARE, 2005, 28 (05) : 1083 - 1091
  • [3] Effects of exenatide (exendin-4) on glycemic control and weight in patients with Type 2 diabetes treated with metformin and a sulfonylurea
    Kendall, DM
    Riddle, MC
    Zhuang, D
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETOLOGIA, 2004, 47 : A279 - A280
  • [4] Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
    Buse, JB
    Henry, RR
    Han, J
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETES CARE, 2004, 27 (11) : 2628 - 2635
  • [5] Effect of exenatide (exendin-4) on glycemic control and safety over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
    Buse, J
    Henry, R
    Han, J
    Kim, DD
    Fineman, M
    Baron, AD
    DIABETES, 2004, 53 : A82 - A82
  • [6] Effect of exenatide (exendin-4) on glycemic control and safety over 30 weeks in sulfonylurea-treated patients with Type 2 diabetes
    Buse, J
    Henry, R
    Han, J
    Kim, D
    Fineman, M
    Baron, AD
    DIABETOLOGIA, 2004, 47 : A280 - A280
  • [7] Effects of exenatide (exendin-4) on glycemic control and weight in overweight patients with type 2 diabetes
    Blonde, L
    Trautmann, M
    Holcombe, J
    Han, J
    Kim, D
    OBESITY RESEARCH, 2004, 12 : A39 - A39
  • [8] Long-term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over-weight metformin-treated patients with type 2 diabetes mellitus
    Ratner, R. E.
    Maggs, D.
    Nielsen, L. L.
    Stonehouse, A. H.
    Poon, T.
    Zhang, B.
    Bicsak, T. A.
    Brodows, R. G.
    Kim, D. D.
    DIABETES OBESITY & METABOLISM, 2006, 8 (04): : 419 - 428
  • [9] Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes
    Fineman, MS
    Bicsak, TA
    Shen, LZ
    Taylor, K
    Gaines, E
    Varns, A
    Kim, D
    Baron, AD
    DIABETES CARE, 2003, 26 (08) : 2370 - 2377
  • [10] Exenatide (Exendin-4) reduced A1C and weight over 82 weeks in overweight patients with type 2 diabetes
    Blonde, L
    Han, J
    Mac, S
    Poon, T
    Taylor, K
    Kim, D
    DIABETES, 2005, 54 : A118 - A118
12345